State Medicaid Hepatitis C Treatment Eligibility Criteria and Use of Direct-Acting Antivirals

27Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Medicaid program criteria for accessing hepatitis C treatment are changing. Medicaid drug utilization data from 2014 to 2016 show that programs that have relaxed their criteria have seen significant increases in treatment utilization, as have states with Medicaid expansions.

Cite

CITATION STYLE

APA

Kapadia, S. N., Jeng, P. J., Schackman, B. R., & Bao, Y. (2018). State Medicaid Hepatitis C Treatment Eligibility Criteria and Use of Direct-Acting Antivirals. Clinical Infectious Diseases, 66(10), 1618–1620. https://doi.org/10.1093/cid/cix1062

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free